Table 1 Clinical and laboratory findings in complete KD and incomplete KD
From: Changes in clinical and laboratory features of Kawasaki disease noted over time in Daejeon, Korea
Complete KD (n = 387) | Incomplete KD (n = 228) | P | |
|---|---|---|---|
Age (month) | 30.9 ± 20.3 | 27.7 ± 22.9 | 0.069 |
Sex (male/female) | 233/154 | 142/86 | 0.669 |
Fever (day) | |||
Preadmission | 4.5 ± 1.7 | 4.6 ± 2.1 | 0.795 |
Total | 6.8 ± 2.6 | 6.6 ± 2.7 | 0.515 |
Hospitalization (day) | 7.6 ± 3.6 | 6.6 ± 3.2 | < 0.001 |
Repeated IVIG, n (%) | 46 (11.9) | 13 (5.7) | 0.015 |
CALs, n (%) | 73 (18.9) | 46 (20.2) | 0.751 |
Ectasia | 69 (17.8) | 42 (18.4) | 0.914 |
Aneurysm | 4 (1.0) | 4 (1.8) | 0.477 |
WBC (/mm3) | 15,000 ± 5100 | 15,000 ± 5000 | 0.991 |
Neutrophil (%) | 66.1 ± 15.4 | 61.3 ± 15.6 | < 0.001 |
Lymphocyte (%) | 22.5 ± 12.4 | 26.8 ± 12.4 | < 0.001 |
Hemoglobin (g/dL) | 11.1 ± 1.1 | 11.2 ± 1.0 | 0.665 |
Platelet (x-103/mm3) | 323 ± 124 | 335 ± 140 | 0.086 |
Platelet, follow-up | 473 ± 189 | 456 ± 174 | 0.098 |
CRP (mg/dL) | 10.0 ± 6.3 | 8.8 ± 5.7 | 0.016 |
ESR (mm/h) | 66 ± 31 | 67 ± 27 | 0.593 |
Total protein (g/dL) | 6.5 ± 0.7 | 6.5 ± 0.6 | 0.995 |
Albumin (g/dL) | 3.6 ± 0.4 | 3.7 ± 0.5 | 0.004 |
AST (IU/L) | 96 ± 161 | 79 ± 241 | 0.304 |
ALT (IU/L) | 127 ± 155 | 95 ± 171 | 0.018 |
ALT <40 IU, n (%) | 164 (42.4) | 123 (53.9) | 0.006 |
ALT 41–99 IU, n (%) | 81 (20.9) | 50 (21.9) | 0.761 |
ALT >100 IU, n (%) | 142 (36.7) | 55 (24.1) | 0.001 |